Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Array BioPharma
Information provided by (Responsible Party):
Array BioPharma Identifier:
First received: January 24, 2013
Last updated: September 30, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)